141 related articles for article (PubMed ID: 18769122)
1. Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.
Tavares TS; Nanus D; Yang XJ; Gudas LJ
Cancer Biol Ther; 2008 Oct; 7(10):1607-18. PubMed ID: 18769122
[TBL] [Abstract][Full Text] [Related]
2. Vitamin A and retinoid signaling in the kidneys.
DiKun KM; Gudas LJ
Pharmacol Ther; 2023 Aug; 248():108481. PubMed ID: 37331524
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Effects of a New Retinoate of the Fungal Cytotoxin Illudin M in Brain Tumor Models.
Linder B; Zoldakova M; Kornyei Z; Köhler LHF; Seibt S; Menger D; Wetzel A; Madarász E; Schobert R; Kögel D; Biersack B
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012321
[TBL] [Abstract][Full Text] [Related]
4. Effect of NOP2 knockdown on colon cancer cell proliferation, migration, and invasion.
Bi J; Huang Y; Liu Y
Transl Cancer Res; 2019 Oct; 8(6):2274-2283. PubMed ID: 35116980
[TBL] [Abstract][Full Text] [Related]
5. Post-natal all-trans-retinoic acid biosynthesis.
Napoli JL
Methods Enzymol; 2020; 637():27-54. PubMed ID: 32359649
[TBL] [Abstract][Full Text] [Related]
6. Bexarotene - a novel modulator of AURKA and the primary cilium in
Chowdhury P; Powell RT; Stephan C; Uray IP; Talley T; Karki M; Tripathi DN; Park YS; Mancini MA; Davies P; Dere R
J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30518623
[TBL] [Abstract][Full Text] [Related]
7. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.
Irigoyen A; Jimenez-Luna C; Benavides M; Caba O; Gallego J; Ortuño FM; Guillen-Ponce C; Rojas I; Aranda E; Torres C; Prados J
PLoS One; 2018; 13(4):e0194844. PubMed ID: 29617451
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA methylation in renal cell carcinoma.
Shenoy N; Vallumsetla N; Zou Y; Galeas JN; Shrivastava M; Hu C; Susztak K; Verma A
J Hematol Oncol; 2015 Jul; 8():88. PubMed ID: 26198328
[TBL] [Abstract][Full Text] [Related]
9. Novel and emerging targeted-based cancer therapy agents and methods.
Hojjat-Farsangi M
Tumour Biol; 2015 Feb; 36(2):543-56. PubMed ID: 25663495
[TBL] [Abstract][Full Text] [Related]
10. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.
Zhou X; Tolstov Y; Arslan A; Roth W; Grüllich C; Pahernik S; Hohenfellner M; Duensing S
Neoplasia; 2014 Dec; 16(12):1028-35. PubMed ID: 25499216
[TBL] [Abstract][Full Text] [Related]
12. The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.
Urvalek A; Laursen KB; Gudas LJ
Subcell Biochem; 2014; 70():129-49. PubMed ID: 24962884
[TBL] [Abstract][Full Text] [Related]
13. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
Ramakrishnan S; Pili R
Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
[TBL] [Abstract][Full Text] [Related]
15. RCDB: Renal Cancer Gene Database.
Ramana J
BMC Res Notes; 2012 May; 5():246. PubMed ID: 22608002
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.
Pili R; Salumbides B; Zhao M; Altiok S; Qian D; Zwiebel J; Carducci MA; Rudek MA
Br J Cancer; 2012 Jan; 106(1):77-84. PubMed ID: 22134508
[TBL] [Abstract][Full Text] [Related]
17. Noncytotoxic differentiation treatment of renal cell cancer.
Negrotto S; Hu Z; Alcazar O; Ng KP; Triozzi P; Lindner D; Rini B; Saunthararajah Y
Cancer Res; 2011 Feb; 71(4):1431-41. PubMed ID: 21303982
[TBL] [Abstract][Full Text] [Related]
18. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
[TBL] [Abstract][Full Text] [Related]
19. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
LaBonte MJ; Wilson PM; Fazzone W; Groshen S; Lenz HJ; Ladner RD
BMC Med Genomics; 2009 Nov; 2():67. PubMed ID: 19948057
[TBL] [Abstract][Full Text] [Related]
20. Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.
Nian H; Bisson WH; Dashwood WM; Pinto JT; Dashwood RH
Carcinogenesis; 2009 Aug; 30(8):1416-23. PubMed ID: 19528666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
